Thwe Htay1, Damaris Rosado2, Dale Quest2, Jessica Giller2, Najjar Haya2, Sarah Ream2, Jorge Cervantes2. 1. Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA. thwe.htay@ttuhsc.edu. 2. Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 5001 El Paso Drive, MSC 21009, El Paso, TX, 79905, USA.
Abstract
PURPOSE OF REVIEW: As the evidence on different blood pressure phenotypes and their cardiovascular risks evolve, it is imperative to evaluate the reliability of office blood pressure (OBP), ambulatory blood pressure (ABP), and home blood pressure (HBP) measurements and their associations with cardiovascular morbidity and mortality. RECENT FINDINGS: HBP is more reliable in diagnosis of hypertension than OBP or ABP. HBP correlates better with left ventricular mass index (LVMI). Increasing systolic HBP is associated with a higher risk of all-cause mortality, cardiovascular mortality, and cardiovascular events. An elevated systolic ABP is also associated with a higher risk of cardiovascular events and mortality. ABP is a better predictor of cardiovascular events than OBP in diabetics. ABP and HBP furnish additional information beyond OBP. They correlate better with cardiovascular outcomes and are more helpful with monitoring therapy than OBP. Comparative effectiveness studies of all three methods associating with cardiovascular outcomes are warranted.
PURPOSE OF REVIEW: As the evidence on different blood pressure phenotypes and their cardiovascular risks evolve, it is imperative to evaluate the reliability of office blood pressure (OBP), ambulatory blood pressure (ABP), and home blood pressure (HBP) measurements and their associations with cardiovascular morbidity and mortality. RECENT FINDINGS: HBP is more reliable in diagnosis of hypertension than OBP or ABP. HBP correlates better with left ventricular mass index (LVMI). Increasing systolic HBP is associated with a higher risk of all-cause mortality, cardiovascular mortality, and cardiovascular events. An elevated systolic ABP is also associated with a higher risk of cardiovascular events and mortality. ABP is a better predictor of cardiovascular events than OBP in diabetics. ABP and HBP furnish additional information beyond OBP. They correlate better with cardiovascular outcomes and are more helpful with monitoring therapy than OBP. Comparative effectiveness studies of all three methods associating with cardiovascular outcomes are warranted.
Authors: Teemu J Niiranen; Marjo-Riitta Hänninen; Jouni Johansson; Antti Reunanen; Antti M Jula Journal: Hypertension Date: 2010-04-12 Impact factor: 10.190
Authors: Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais Journal: J Hypertens Date: 2018-10 Impact factor: 4.844
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: J Am Coll Cardiol Date: 2017-11-13 Impact factor: 24.094
Authors: José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Ernest Vinyoles; Manuel Gorostidi; Juan J de la Cruz; Julián Segura; Anna Oliveras; Nieves Martell; Juan García-Puig; Bryan Williams Journal: Hypertension Date: 2016-12-27 Impact factor: 10.190
Authors: P Verdecchia; G Schillaci; C Borgioni; A Ciucci; I Zampi; R Gattobigio; N Sacchi; C Porcellati Journal: Am J Hypertens Date: 1995-08 Impact factor: 2.689
Authors: Thomas G Pickering; William Gerin; Joseph E Schwartz; Tanya M Spruill; Karina W Davidson Journal: J Hypertens Date: 2008-12 Impact factor: 4.844
Authors: Adam P Bress; Jordana B Cohen; David Edmund Anstey; Molly B Conroy; Keith C Ferdinand; Valy Fontil; Karen L Margolis; Paul Muntner; Morgan M Millar; Kolawole S Okuyemi; Michael K Rakotz; Kristi Reynolds; Monika M Safford; Daichi Shimbo; John Stuligross; Beverly B Green; April F Mohanty Journal: J Am Heart Assoc Date: 2021-05-19 Impact factor: 5.501